{"PixelsPerMicron": 1.5385, "Images": [{"Name": "i0", "Description": "HTA MEL Atlas 1: Deep Exploration of a Primary Melanoma", "Path": "https://s3.amazonaws.com/www.cycif.org/nirmal-vallius-maliga-2021/Z147-FullStory", "Width": 36857, "Height": 25808, "MaxLevel": 6}], "Header": "", "Rotation": 0, "Layout": {"Grid": [["i0"]]}, "Stories": [{"Name": "", "Description": "", "Waypoints": [{"Name": "Overview of sample MEL1", "Description": "In this Story, we are giving a tour of a unique sample of a NF1 mut, BRAF wt melanoma, which contains multiple fields of disease progression. From left to right, the regions highlighted show melanoma in situ, polypoid exophytic tumor growth, and regions of invasive melanoma. Throughout this Story, we present findings from our paper that describe and deeply characterize these unique regions by CyCIF, single-cell profiling, and microregional sequencing. Each of these heterogeneous areas are comprised of different cell types ranging from keratinocytes (Pan-CK+) and melanocytes (SOX10+) to various subsets of immune (CD3d+ T cells, CD11C+ and/or CD163+ myeloid cells) and stromal cells, which we will discuss and highlight later.\n", "Arrows": [], "Overlays": [{"x": 0.4970893426396783, "y": 0.526789269856613, "width": 0.12083475331022786, "height": 0.09859522816110622}, {"x": 0.3150818397894717, "y": 0.7425803905703474, "width": 0.15141380386326814, "height": 0.04765307532752594}, {"x": 0.8980634145625118, "y": 0.3728847577874439, "width": 0.28783994693804027, "height": 0.2079057560660611}], "Group": "Tissue architecture", "Masks": [], "ActiveMasks": [], "Zoom": 0.8096268069425859, "Pan": [0.5936986108576682, 0.5857864007830037]}, {"Name": "Melanoma in Situ", "Description": "A closer look of the Melanoma In Situ (MIS) region illustrates the horizontal axis of melanoma regression from left to right with a decreasing number of melanocytes (SOX10+, green) in the Pan-CK (pan Cytokeratin)+ epidermis. The region highlighted in the left contains MIS with dermal macrophages and a moderate T cell (CD3d+) infiltration in the adjacent dermal region. The MIS region with inflammatory regression in the middle is characterized by the presence and abundance of T cells and myeloid cells (CD11c+ and/or CD163+) in the dermal field which directly abuts epidermis. Notably, a majority of the T cells infiltrating into epidermis within this region are exhausted (PD1+ TIM3+ and/or LAG3+; data shown in Waypoint #13). The terminal regression of melanoma does not contain any melanocytes, but harbors a dense infiltrate of T cells.\n\n", "Arrows": [], "Overlays": [{"x": 0.42432201930199176, "y": 0.7523015075590233, "width": 0.03778705615360167, "height": 0.02334809973718477}, {"x": 0.3679486469102363, "y": 0.7530695371556412, "width": 0.05550293884892177, "height": 0.015360591932358392}, {"x": 0.4627234991328878, "y": 0.7347392307830267, "width": 0.029389932563912424, "height": 0.03220604108484493}], "Group": "Tissue architecture MIS", "Masks": [], "ActiveMasks": [], "Zoom": 6.076694881172611, "Pan": [0.41382561481488017, 0.7600842074714181]}, {"Name": "Invasive melanoma", "Description": "The invasive melanoma region has an abundance of SOX10+ tumor cells invading into the dermis (highlighted with arrows). The adjacent stroma harbors dense infiltrates of T cells (CD3d+) and dendritic cells (CD11C+). The endothelial cells (CD31+) and myofibroblasts (aSMA+) are forming vascular structures.", "Arrows": [{"Text": "", "HideArrow": false, "Point": [0.9694848528812916, 0.575879617745158], "Angle": 60}, {"Text": "", "HideArrow": false, "Point": [1.125781563822966, 0.4891504988958153], "Angle": 60}], "Overlays": [], "Group": "Tissue architecture IM", "Masks": [], "ActiveMasks": [], "Zoom": 1.949434859886262, "Pan": [0.9870851678261275, 0.48611801152649436]}, {"Name": "Exophytic tumor growth", "Description": "The exophytic tumor component has dense areas of SOX10+ tumor cells. CD11C+ myeloid cells (magenta) line the vascular structures (CD31+, red), but can also be seen infiltrating the tumor region (arrows). The CD3+ T cells (yellow) are however restricted to the regions surrounding the vasculature and are being excluded from the tumor region.\n", "Arrows": [{"Text": "", "HideArrow": false, "Point": [0.5405100124587578, 0.5983856292167941], "Angle": 60}, {"Text": "", "HideArrow": false, "Point": [0.5865300617309137, 0.5977735124791959], "Angle": 60}], "Overlays": [], "Group": "Tissue architecture EM", "Masks": [], "ActiveMasks": [], "Zoom": 5.605249030285797, "Pan": [0.5586509266821228, 0.5826931819438219]}, {"Name": "Fields of active immune editing", "Description": "Immune active and suppressive regions can exist close to one another in the same sample. The left-hand box is a region of inflammatory regression and the right-hand box is the stroma adjacent to the invasive boundary. Although both of these regions contain abundant exhausted T cells, the outcome of the immune editing process depends on their interactions with other neighboring stromal cells and their proximity to tumor cells (i.e. different immune editing in the melanoma in situ (MIS) versus invasive melanoma (IM); leading to tumor regression in the MIS and the formation of a resulting protective tumor microenvironment in the IM).", "Arrows": [], "Overlays": [{"x": 0.9735529382196777, "y": 0.557137937912678, "width": 0.0381239368635522, "height": 0.03220177191387408}, {"x": 0.42316173320897876, "y": 0.752199245942697, "width": 0.04996826676290811, "height": 0.02146784794258283}], "Group": "Immune editing", "Masks": [], "ActiveMasks": [], "Zoom": 1.0863348142548606, "Pan": [0.6154470264188363, 0.596927483668327]}, {"Name": "Immune suppression", "Description": "Here we highlight a niche of PDL1 positive myeloid cells which lines the invasive boundary as an immune suppressive barrier. Regulatory T cells were uniformly distributed within the different regions of the tumor, however, the invasive boundary was the only region where an interaction between regulatory T cells and exhausted T cells was observed.", "Arrows": [], "Overlays": [], "Group": "Immune suppression", "Masks": [], "ActiveMasks": [], "Zoom": 8.071558603611548, "Pan": [0.9740026416224572, 0.5632577493524179]}, {"Name": "Single-cell segmentation and phenotyping", "Description": "This macro-level view of the entire specimen illustrates the single-cell phenotyping performed for quantification. After single-cell segmentation, each individual cell was assigned into a specific phenotypic category. Here, the broad phenotypic categories are highlighted with colored segmentation masks: tumor (green), T cells (cyan), myeloid cells (yellow) and vasculature (red).", "Arrows": [], "Overlays": [], "Group": "Single-cell phenotyping", "Masks": ["T1", "T2", "T3", "T4", "T5a", "T5b", "Melanocytes", "CD163+ CD11C+ PDL1+ macrophages", "CD163+ CD11C+ macrophages", "CD11C+ CD163- PDL1+ cells", "CD11C+ CD163- cells", "CD163+ CD11C-  macrophages", "Langerhan cells", "Mast cells", "Other APCs", "Partially Exhausted T cells", "Terminally Exhausted T cells", "T cells", "Cytotoxic T cells", "Regulatory T cells", "Keratinocytes", "Blood Vessels", "Myofibroblast"], "ActiveMasks": ["T1", "T2", "T3", "T4", "T5a", "T5b", "Melanocytes", "CD163+ CD11C+ PDL1+ macrophages", "CD163+ CD11C+ macrophages", "CD11C+ CD163- PDL1+ cells", "CD11C+ CD163- cells", "CD163+ CD11C-  macrophages", "Langerhan cells", "Mast cells", "Other APCs", "Partially Exhausted T cells", "Terminally Exhausted T cells", "T cells", "Cytotoxic T cells", "Regulatory T cells", "Keratinocytes", "Blood Vessels", "Myofibroblast"], "Zoom": 0.5876070528967252, "Pan": [0.5541660309962447, 0.5581545916997968]}, {"Name": "Detailed cell phenotyping in the invasive region", "Description": "This view represents the single-cell phenotyping within the invasive melanoma region. The broad phenotypes highlighted here are tumor (green), T cells (cyan), myeloid cells (yellow) and vasculature (red). Identifying specific phenotypes allows us to study cell-to-cell interactions and the tissue structure in great detail.", "Arrows": [], "Overlays": [], "Group": "Single-cell phenotyping", "Masks": ["T1", "T2", "T3", "T4", "T5a", "T5b", "Melanocytes", "CD163+ CD11C+ PDL1+ macrophages", "CD163+ CD11C+ macrophages", "CD11C+ CD163- PDL1+ cells", "CD11C+ CD163- cells", "CD163+ CD11C-  macrophages", "Langerhan cells", "Mast cells", "Other APCs", "Partially Exhausted T cells", "Terminally Exhausted T cells", "T cells", "Cytotoxic T cells", "Regulatory T cells", "Keratinocytes", "Blood Vessels", "Myofibroblast"], "ActiveMasks": ["T1", "T2", "T3", "T4", "T5a", "T5b", "Melanocytes", "CD163+ CD11C+ PDL1+ macrophages", "CD163+ CD11C+ macrophages", "CD11C+ CD163- PDL1+ cells", "CD11C+ CD163- cells", "CD163+ CD11C-  macrophages", "Langerhan cells", "Mast cells", "Other APCs", "Partially Exhausted T cells", "Terminally Exhausted T cells", "T cells", "Cytotoxic T cells", "Regulatory T cells", "Keratinocytes", "Blood Vessels", "Myofibroblast"], "Zoom": 6.287892256926162, "Pan": [1.107390076882973, 0.47635531376622875]}, {"Name": "Intratumor heterogeneity", "Description": "To study similarities and differences among SOX10+ tumor cells (green), we performed unsupervised clustering using 30 different CyCIF markers following single-cell phenotyping. This yielded six clusters (T1-4, T5a and T5b), which were differentiated by the expression of melanoma associated markers. The violin plot below illustrates the marker expression as well as the percentage of total tumor cells that make up each tumor cell cluster. The spatial information linked to the single-cell data allowed us to observe that a proportion of the clusters were spatially organized.![](../images/full_story_waypoint10_Intratumor_heterogeneity_v3.png)", "Arrows": [], "Overlays": [], "Group": "Tumor clusters", "Masks": ["T1-0", "T2-0", "T3-0", "T4-0", "T5a-0", "T5b-0"], "ActiveMasks": ["T1-0", "T2-0", "T3-0", "T4-0", "T5a-0", "T5b-0"], "Zoom": 4.835065383003301, "Pan": [0.5557071303437275, 0.6107415395692443]}, {"Name": "Spatially restricted tumor states I", "Description": "Cluster T5b was spatially restricted to the invasive boundary and predominantly showed SOX10+ tumor cells expressing high levels of major histocompatibility complex-II (MHC-II). Although MHC-II is primarily expressed on antigen presenting immune cells, exposure to interferon gamma (IFNy) can lead to up-regulation of MHC-II also in tumor cells. These MHC-II-high cells were enriched at the leading edge of the invasive melanoma adjacent to the stroma (arrow) suggesting signals from the tumor microenvironment can drive tumor heterogeneity. We observed an up-regulation of interferon-gamma in the invasive boundary of the invasive melanoma via microregional transcriptomics (inset top). Additionally, neighborhood analysis revealed there was a significant co-occurrence between PDL1+ macrophages and cells in cluster T5b (inset bottom).\n![](../images/full_story_waypoint12_spatially_restricted_tumor_states_II_v3.jpg)", "Arrows": [{"Text": "", "HideArrow": false, "Point": [1.1292582657321801, 0.4360924375867877], "Angle": 60}], "Overlays": [], "Group": "MHC-II-high cluster T5a", "Masks": [], "ActiveMasks": [], "Zoom": 6.24712042393971, "Pan": [1.1127333353992994, 0.4262244870786548]}, {"Name": "Spatially restricted tumor states II", "Description": "A second spatially restricted cluster (cluster T5a) was characterized by Cyclin D1-high (CCDN1 high) tumor cells, which primarily surrounded perivascular spaces within the exophytic tumor region. These cells had a distinct spindle-like morphology with lengthened nuclei (arrows).\n", "Arrows": [{"Text": "", "HideArrow": false, "Point": [0.5682151599494634, 0.5792353770384463], "Angle": 60}, {"Text": "", "HideArrow": false, "Point": [0.5822731935776629, 0.5777838783464333], "Angle": 60}], "Overlays": [], "Group": "CCND1-high cluster T5b", "Masks": [], "ActiveMasks": [], "Zoom": 11.080045385806857, "Pan": [0.5765747172312417, 0.5795848119087457]}, {"Name": "T cell exhaustion in the invasive region", "Description": "When evaluating the immune subsets in the various stages of melanoma progression, we observed that T cells were abundant in the stromal region adjacent to the invasive tumor boundary -- this is what we refer to as the brisk tumor infiltrating lymphocyte (bTIL) region outlined in the box. Although a minor proportion of T cells are infiltrating the tumor region (arrows), the majority of T cells are restricted to the stroma. Here, the majority of CD8+ T cells (refered to as CTLs) are either activated (PD1+) or exhausted (PD1+ TIM3+ and/or LAG3+). TIM3+ CD8- cells were further identified as CD11C+ dendritic cells (data not shown). Microregional transcriptomics highlights that genes related to T cell exhaustion were up-regulated within the bTIL region in comparison to the exophytic melanoma (EM) region (inset).![](../images/full_story_waypoint13_Tcell_exhaustion_in_the_invasive_region_v2.png)", "Arrows": [{"Text": "", "HideArrow": false, "Point": [0.9961082856413875, 0.5470280717889902], "Angle": 60}, {"Text": "", "HideArrow": false, "Point": [0.9630887512160567, 0.5452756383977017], "Angle": 60}], "Overlays": [{"x": 0.9818582351701205, "y": 0.5704092225622341, "width": 0.020337450672584967, "height": 0.016048600530747303}], "Group": "T cell exhaustion", "Masks": [], "ActiveMasks": [], "Zoom": 8.718992249502227, "Pan": [0.9731652432159656, 0.5574504388003376]}, {"Name": "Cytotoxic T cell enrichment in the region of inflammatory regression", "Description": "In this sample, the cytotoxic CD8+ T cells (white) that did not express any exhaustion markers (arrow) were in the minority (0.1% of all cells). However, they were notably enriched in the dermal region of MIS with inflammatory regression (IR; highlighted with a rectangle and seen in the inset). We also observed epidermal infiltration of exhausted T cells (TIM3+: red, and/or LAG3+: magenta) within this specific region.\n\n![](../images/full_story_waypoint14_cytotoxic_T_cell_enrichement_v2.png)", "Arrows": [{"Text": "", "HideArrow": false, "Point": [0.44445356605377934, 0.7674636440913258], "Angle": 60}], "Overlays": [{"x": 0.41791673230498827, "y": 0.7531915052242946, "width": 0.03608902272783798, "height": 0.02338421370630317}], "Group": "Cytotoxic T cells MIS", "Masks": [], "ActiveMasks": [], "Zoom": 9.733242876834158, "Pan": [0.4331294018565221, 0.7587652773225894]}, {"Name": "Identification and characterization of cell to cell interactions", "Description": "The spatial cell to cell proximity analysis revealed significant co-localization of CD11C+ PD-L1+ dendritic cells (orange) and terminally exhausted TIM3+ T cells (cyan), suggesting PDL1-PD1 ligand-receptor interactions between these cell types and that PDL1+ myeloid cells are one major driver of immune suppression within melanoma tumor microenvironment.\n<video width=\"320\" height=\"180\" controls autoplay muted loop><source src=\"../images/PCA_22.mp4\" type=\"video/mp4\"></video>", "Arrows": [], "Overlays": [], "Group": "Cell to cell interactions", "Masks": ["CD11C+ CD163- PDL1+ cells", "Terminally Exhausted T cells"], "ActiveMasks": ["CD11C+ CD163- PDL1+ cells", "Terminally Exhausted T cells"], "Zoom": 7.517169492586512, "Pan": [0.9502161635608937, 0.5521550802969822]}]}], "Masks": [{"Path": "all-cells", "Name": "all cells", "Colors": ["ffffff"], "Channels": ["all cells"]}, {"Path": "Unknown", "Name": "Unknown", "Colors": ["308e36"], "Channels": ["Unknown"]}, {"Path": "Blood-Vessels", "Name": "Blood Vessels", "Colors": ["ff0000"], "Channels": ["Blood Vessels"]}, {"Path": "CD11C-CD163-cells", "Name": "CD11C+ CD163- cells", "Colors": ["ffbb00"], "Channels": ["CD11C+ CD163- cells"]}, {"Path": "Keratinocytes", "Name": "Keratinocytes", "Colors": ["00ffff"], "Channels": ["Keratinocytes"]}, {"Path": "Other-APCs", "Name": "Other APCs", "Colors": ["ffbb00"], "Channels": ["Other APCs"]}, {"Path": "Myofibroblast", "Name": "Myofibroblast", "Colors": ["ff0000"], "Channels": ["Myofibroblast"]}, {"Path": "Regulatory-T-cells", "Name": "Regulatory T cells", "Colors": ["00ffff"], "Channels": ["Regulatory T cells"]}, {"Path": "T-cells", "Name": "T cells", "Colors": ["00ffff"], "Channels": ["T cells"]}, {"Path": "Mast-cells", "Name": "Mast cells", "Colors": ["ffbb00"], "Channels": ["Mast cells"]}, {"Path": "CD163-CD11C-macrophages", "Name": "CD163+ CD11C+ macrophages", "Colors": ["ffbb00"], "Channels": ["CD163+ CD11C+ macrophages"]}, {"Path": "T1", "Name": "T1", "Colors": ["116800"], "Channels": ["T1"]}, {"Path": "CD11C-CD163-PDL1-cells", "Name": "CD11C+ CD163- PDL1+ cells", "Colors": ["ffbb00"], "Channels": ["CD11C+ CD163- PDL1+ cells"]}, {"Path": "Melanocytes", "Name": "Melanocytes", "Colors": ["116800"], "Channels": ["Melanocytes"]}, {"Path": "Partially-Exhausted-T-cells", "Name": "Partially Exhausted T cells", "Colors": ["00ffff"], "Channels": ["Partially Exhausted T cells"]}, {"Path": "CD163-CD11C-macrophages-0", "Name": "CD163+ CD11C-  macrophages", "Colors": ["ffbb00"], "Channels": ["CD163+ CD11C-  macrophages"]}, {"Path": "Terminally-Exhausted-T-cells", "Name": "Terminally Exhausted T cells", "Colors": ["00ffff"], "Channels": ["Terminally Exhausted T cells"]}, {"Path": "T2", "Name": "T2", "Colors": ["116800"], "Channels": ["T2"]}, {"Path": "T4", "Name": "T4", "Colors": ["116800"], "Channels": ["T4"]}, {"Path": "T5b", "Name": "T5b", "Colors": ["116800"], "Channels": ["T5b"]}, {"Path": "CD163-CD11C-PDL1-macrophages", "Name": "CD163+ CD11C+ PDL1+ macrophages", "Colors": ["ffc500"], "Channels": ["CD163+ CD11C+ PDL1+ macrophages"]}, {"Path": "Cytotoxic-T-cells", "Name": "Cytotoxic T cells", "Colors": ["00ffff"], "Channels": ["Cytotoxic T cells"]}, {"Path": "Langerhan-cells", "Name": "Langerhan cells", "Colors": ["ffbb00"], "Channels": ["Langerhan cells"]}, {"Path": "T5a", "Name": "T5a", "Colors": ["116800"], "Channels": ["T5a"]}, {"Path": "T3", "Name": "T3", "Colors": ["116800"], "Channels": ["T3"]}, {"Path": "Unknown-0", "Name": "Unknown-0", "Colors": ["308e36"], "Channels": ["Unknown"]}, {"Path": "Blood-Vessels-0", "Name": "Blood Vessels-0", "Colors": ["a79b38"], "Channels": ["Blood Vessels"]}, {"Path": "CD11C-CD163-cells-0", "Name": "CD11C+ CD163- cells-0", "Colors": ["6c1118"], "Channels": ["CD11C+ CD163- cells"]}, {"Path": "Keratinocytes-0", "Name": "Keratinocytes-0", "Colors": ["582eb3"], "Channels": ["Keratinocytes"]}, {"Path": "Other-APCs-0", "Name": "Other APCs-0", "Colors": ["4c044f"], "Channels": ["Other APCs"]}, {"Path": "Myofibroblast-0", "Name": "Myofibroblast-0", "Colors": ["2e41a5"], "Channels": ["Myofibroblast"]}, {"Path": "Regulatory-T-cells-0", "Name": "Regulatory T cells-0", "Colors": ["560b47"], "Channels": ["Regulatory T cells"]}, {"Path": "T-cells-0", "Name": "T cells-0", "Colors": ["5a1745"], "Channels": ["T cells"]}, {"Path": "Mast-cells-0", "Name": "Mast cells-0", "Colors": ["0e4f4c"], "Channels": ["Mast cells"]}, {"Path": "CD163-CD11C-macrophages-1", "Name": "CD163+ CD11C+ macrophages-0", "Colors": ["0c6342"], "Channels": ["CD163+ CD11C+ macrophages"]}, {"Path": "T1-0", "Name": "T1-0", "Colors": ["00ff00"], "Channels": ["T1"]}, {"Path": "CD11C-CD163-PDL1-cells-0", "Name": "CD11C+ CD163- PDL1+ cells-0", "Colors": ["a32ac1"], "Channels": ["CD11C+ CD163- PDL1+ cells"]}, {"Path": "Melanocytes-0", "Name": "Melanocytes-0", "Colors": ["1e4a12"], "Channels": ["Melanocytes"]}, {"Path": "Patially-Exhausted-T-cells", "Name": "Patially Exhausted T cells", "Colors": ["3b082c"], "Channels": ["Patially Exhausted T cells"]}, {"Path": "CD163-CD11C-macrophages-2", "Name": "CD163+ CD11C-  macrophages-0", "Colors": ["48ce65"], "Channels": ["CD163+ CD11C-  macrophages"]}, {"Path": "Terminally-Exhausted-T-cells-0", "Name": "Terminally Exhausted T cells-0", "Colors": ["c5b712"], "Channels": ["Terminally Exhausted T cells"]}, {"Path": "T2-0", "Name": "T2-0", "Colors": ["ff00ff"], "Channels": ["T2"]}, {"Path": "T4-0", "Name": "T4-0", "Colors": ["00ffff"], "Channels": ["T4"]}, {"Path": "T5b-0", "Name": "T5b-0", "Colors": ["ff0000"], "Channels": ["T5b"]}, {"Path": "CD163-CD11C-PDL1-macrophages-0", "Name": "CD163+ CD11C+ PDL1+ macrophages-0", "Colors": ["065411"], "Channels": ["CD163+ CD11C+ PDL1+ macrophages"]}, {"Path": "Cytotoxic-T-cells-0", "Name": "Cytotoxic T cells-0", "Colors": ["a79b34"], "Channels": ["Cytotoxic T cells"]}, {"Path": "Langerhan-cells-0", "Name": "Langerhan cells-0", "Colors": ["360948"], "Channels": ["Langerhan cells"]}, {"Path": "T5a-0", "Name": "T5a-0", "Colors": ["ffffff"], "Channels": ["T5a"]}, {"Path": "T3-0", "Name": "T3-0", "Colors": ["ffff00"], "Channels": ["T3"]}], "Groups": [{"Name": "Tissue architecture MIS", "Path": "Tissue-architecture-MIS_0__DNA--10__CD3D--30__CD11C--9__CD163--6__Pan-CK--3__SOX10", "Colors": ["0000ff", "ff0000", "ffbb00", "ffbb00", "ffffff", "00ff00"], "Channels": ["DNA", "CD3D", "CD11C", "CD163", "Pan-CK", "SOX10"]}, {"Name": "Single-cell phenotyping", "Path": "Single-cell-phenotyping_0__DNA--10__CD3D--11__CD8A--30__CD11C--15__PDL1", "Colors": ["ffffff", "ff0000", "ff0000", "00ff00", "ff00ff"], "Channels": ["DNA", "CD3D", "CD8A", "CD11C", "PDL1"]}, {"Name": "T cell exhaustion", "Path": "T-cell-exhaustion_11__CD8A--18__LAG3--31__PD1--3__SOX10--19__TIM3", "Colors": ["ffffff", "ff00ff", "0000ff", "00ff00", "ff0000"], "Channels": ["CD8A", "LAG3", "PD1", "SOX10", "TIM3"]}, {"Name": "MHC-II-high cluster T5a", "Path": "MHC-II-high-cluster-T5a_0__DNA--27__HLADPB1--3__SOX10", "Colors": ["0000ff", "ff0000", "00ff00"], "Channels": ["DNA", "HLADPB1", "SOX10"]}, {"Name": "CCND1-high cluster T5b", "Path": "CCND1-high-cluster-T5b_37__CCND1--3__SOX10", "Colors": ["ff0000", "00ff00"], "Channels": ["CCND1", "SOX10"]}, {"Name": "Tissue architecture", "Path": "Tissue-architecture_0__DNA--26__aSMA--39__CD31--6__Pan-CK--3__SOX10", "Colors": ["0000ff", "00ffff", "ff0000", "ffffff", "00ff00"], "Channels": ["DNA", "aSMA", "CD31", "Pan-CK", "SOX10"]}, {"Name": "Tissue architecture IM", "Path": "Tissue-architecture-IM_0__DNA--26__aSMA--10__CD3D--30__CD11C--39__CD31--3__SOX10", "Colors": ["0000ff", "ffff00", "ff0000", "ffb600", "ffff00", "00ff00"], "Channels": ["DNA", "aSMA", "CD3D", "CD11C", "CD31", "SOX10"]}, {"Name": "Tissue architecture EM", "Path": "Tissue-architecture-EM_26__aSMA--10__CD3D--30__CD11C--39__CD31--3__SOX10", "Colors": ["ff0000", "ffff00", "ff00ff", "ff0000", "00ff00"], "Channels": ["aSMA", "CD3D", "CD11C", "CD31", "SOX10"]}, {"Name": "Cytotoxic T cells MIS", "Path": "Cytotoxic-T-cells-MIS_11__CD8A--6__Pan-CK--18__LAG3--31__PD1--3__SOX10--19__TIM3", "Colors": ["ffffff", "ffbb00", "ff00ff", "0000ff", "00ff00", "ff0000"], "Channels": ["CD8A", "Pan-CK", "LAG3", "PD1", "SOX10", "TIM3"]}, {"Name": "Cell to cell interactions", "Path": "Cell-to-cell-interactions_11__CD8A--30__CD11C--15__PDL1--3__SOX10--19__TIM3", "Colors": ["ffffff", "a800ff", "0000ff", "00ff00", "ff0000"], "Channels": ["CD8A", "CD11C", "PDL1", "SOX10", "TIM3"]}, {"Name": "Tumor clusters", "Path": "Tumor-clusters_0__DNA--6__Pan-CK--3__SOX10", "Colors": ["0000ff", "ffffff", "00ff00"], "Channels": ["DNA", "Pan-CK", "SOX10"]}, {"Name": "Immune suppression", "Path": "Immune-suppression_3__SOX10--30__CD11C--15__PDL1--11__CD8A--14__FOXP3", "Colors": ["00ff00", "00ffff", "ff00ff", "ffff00", "ff0000"], "Channels": ["SOX10", "CD11C", "PDL1", "CD8A", "FOXP3"]}, {"Name": "Immune editing", "Path": "Immune-editing_0__DNA--3__SOX10--11__CD8A--31__PD1--19__TIM3", "Colors": ["0000ff", "00ff00", "00ffff", "ffffff", "ff0000"], "Channels": ["DNA", "SOX10", "CD8A", "PD1", "TIM3"]}, {"Name": "Intratumor heterogeneity", "Path": "Intratumor-heterogeneity_11__CD8A--30__CD11C--15__PDL1--3__SOX10--19__TIM3", "Colors": ["00ffff", "ff0000", "ffff00", "00ff00", "ff0000"], "Channels": ["CD8A", "CD11C", "PDL1", "SOX10", "TIM3"]}]}
